title: Outcomes of splenectomy versus cladribine for hairy cell leukemia in resource limited settings.
authors.affiliation: Clinical Hematology, Department of Internal Medicine.
authors.forename: Deepesh P
authors.initials: DP
authors.lastname: Lad
authors.forename: Pankaj
authors.initials: P
authors.lastname: Malhotra
authors.forename: Alka
authors.initials: A
authors.lastname: Khadwal
authors.forename: Gaurav
authors.initials: G
authors.lastname: Prakash
authors.forename: Vikas
authors.initials: V
authors.lastname: Suri
authors.forename: Savita
authors.initials: S
authors.lastname: Kumari
authors.forename: Sanjay
authors.initials: S
authors.lastname: Jain
authors.forename: Reena
authors.initials: R
authors.lastname: Das
authors.forename: Neelam
authors.initials: N
authors.lastname: Varma
authors.forename: Subhash
authors.initials: S
authors.lastname: Varma
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017338:Cladribine / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D003906:Developing Countries; D006801:Humans; D007943:Leukemia, Hairy Cell / Q000188:drug therapy* / Q000601:surgery*; D012189:Retrospective Studies; D013156:Splenectomy; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D017338:Cladribine